DiaMedica Therapeutics Inc. Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -4.26M-5.73M-10.65M-12.29M-13.59M-13.68M-19.38M-24.44M
Depreciation and Depletion 0.00M0.01M0.02M0.02M0.02M0.03M0.03M0.04M
Share-based Compensation 0.41M0.62M1.16M1.84M1.56M1.50M1.68M2.08M
Gains from Investment Securities 0.01M0.20M0.07M0.04M0.13M0.45M0.01M0.03M
Non-cash Items 1.40M
Cash from Operations -3.90M-5.70M-9.10M-9.19M-12.25M-11.51M-18.73M-22.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00M-0.16M0.01M1.22M1.34M
Depreciation & Amortization (CF) 0.00M0.01M0.02M0.02M0.02M0.03M0.03M0.04M
Change in Working Capital
Change in Receivables 0.03M0.70M0.04M-0.48M-0.21M-0.05M0.29M-0.13M
Change in Account Payables -0.03M-0.30M0.92M-0.59M0.23M0.19M0.01M
Change in Accured Expenses 0.25M0.40M0.23M-0.27M0.04M0.37M0.35M2.49M
Other Working Capital Changes -0.01M0.31M-0.32M0.02M0.12M0.05M0.16M-0.18M
Investing Activities
Capital Expenditures 0.02M0.05M0.00M0.05M0.02M0.08M0.02M0.03M
Sales of Property, Plant and Equipment 0.01M0.02M0.00M
Change in Acquisitions & Divestments 9.00M23.64M49.30M57.30M51.13M59.00M
Cash from Investing Activities -0.02M-0.05M-3.91M-16.13M-20.54M11.54M-18.30M8.56M
Financing Activities
Cash from Financing Activities 3.54M21.22M0.07M28.84M30.09M-0.01M36.84M11.99M
Additional items
Change in Cash -0.38M15.47M-12.94M3.53M-2.70M0.02M-0.18M-1.52M
Free Cash Flow -3.92M-5.75M-9.10M-9.23M-12.27M-11.59M-18.75M-22.12M
Net Cash Flow -0.38M15.47M-12.94M3.53M-2.70M0.02M-0.18M-1.54M